Supervillin‐Mediated ZO‐1 Downregulation Facilitates Migration of Cisplatin‐Resistant HCT116 Colorectal Cancer Cells
Journal of Cellular Biochemistry · 2025
DOI: 10.1002/jcb.30699 ↗At a glance
Journal article in Journal of Cellular Biochemistry, 2025. Written by Yali Hong and 6 co-authors. Institution: Department of Pharmacy, Sir Run Run Hospital Nanjing Medical University, Nanjing, Jiangsu, China. Major MEDLINE topics: Cisplatin, Colorectal Neoplasms, Cell Movement, Drug Resistance, Neoplasm. Cited 3 times so far (Crossref); 48 references. Funded by: This study was supported by Medical Science and Technology Development Foundation of Nanjing Municipality Health Bureau YKK (23203) and National Natural Scienc….
Abstract (original language)
Supervillin (SVIL), the biggest member of the villin/gelsolin superfamily, has recently been reported to promote the metastasis of hepatocellular carcinoma by stimulating epithelial‐mesenchymal transition (EMT). However, little is known about the roles of SVIL in the migration of colorectal cancer cells. Here, we investigated the effects of SVIL on the migration of cisplatin‐resistant colorectal cancer cells. The model of cisplatin‐resistant HCT116 cells (HCT116/DDP) was established. Migration was assessed after SVIL knockdown. Tumor metastasis was assessed using a mouse model with tail vein injection of colorectal cancer cells. The results showed that the expression of SVIL was upregulated in HCT116/DDP cells compared to that in their parental cells. Also, the HCT116/DDP cells showed increased cell migration and lung metastasis. Furthermore, we revealed that the expression of SVIL was associated with the migration of HCT116/DDP cells. Reduced SVIL expression inhibited migration and lung metastasis in HCT116/DDP cells. Further work showed that SVIL knockdown blocked cell migration by targeting zona occludens‐1 (ZO‐1) mediated tight‐junction remodeling. The expression of ZO‐1, but not occludin and cludin5, was downregulated after SVIL knockdown. Immunofluorescence indicated that the linear ZO‐1 was interrupted while the SVIL knockdown reversed the interruption. This study displayed the relationship between SVIL and ZO‐1 in cisplatin‐resistant colon cancer cells, providing a new insight into the mechanism of colorectal cancer migration.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacy, Sir Run Run Hospital Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu, China.
ORCID profiles: Shengnan Li, Lai Jin
Funding
- This study was supported by Medical Science and Technology Development Foundation of Nanjing Municipality Health Bureau YKK (23203) and National Natural Scienc…
Cite
APA
Hong, Y., Li, X., Mao, R., Zhou, F., Li, S., Zhu, C., & Jin, L. (2025). Supervillin‐Mediated ZO‐1 Downregulation Facilitates Migration of Cisplatin‐Resistant HCT116 Colorectal Cancer Cells. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.30699
Vancouver
Hong Y, Li X, Mao R, Zhou F, Li S, Zhu C, et al. Supervillin‐Mediated ZO‐1 Downregulation Facilitates Migration of Cisplatin‐Resistant HCT116 Colorectal Cancer Cells. Journal of Cellular Biochemistry. 2025. doi:10.1002/jcb.30699
BibTeX
@article{Hong2025,
author = {Hong, Yali and Li, Xu and Mao, Rongchen and Zhou, Feier and Li, Shengnan and Zhu, Chao and Jin, Lai},
title = {Supervillin‐Mediated ZO‐1 Downregulation Facilitates Migration of Cisplatin‐Resistant HCT116 Colorectal Cancer Cells},
journal = {Journal of Cellular Biochemistry},
year = {2025},
doi = {10.1002/jcb.30699}
}
EUVIMED